| Holstein SA, Stokes JB, Hohl RJ
Renal failure and recovery associated with second-generation Bcr-Abl kinase inhibitors in imatinib-resistant chronic myelogenous leukemia. [JOURNAL ARTICLE]
Leuk Res 2008 Oct 1.
Abstract | Full Citation | | Miyoshi T, Yamashita K, Ohno T, et al.
Familial Mediterranean Fever Gene as a Possible Modifier of Sweet Syndrome with Chronic Myelogenous Leukemia. [JOURNAL ARTICLE]
Acta Haematol 2008 Sep 30; 120(1):57-62.
Abstract | Full Citation | | Yi SJ, Lee HT, Groffen J, et al.
Bcr/Abl P190 interaction with Spa-1, a GTPase activating protein for the small GTPase Rap1. [Journal Article]
Int J Mol Med 2008 Oct; 22(4):453-8.
Abstract | Full Citation | | Sevinc A, Aydogdu I
Extramedullary myeloid leukemia mimicking lepromatous leprosy. [Journal Article]
J Natl Med Assoc 2008 Sep; 100(9):1036-8.
Abstract | Full Citation | | Skoumalova I, Vondrakova J, Rohon P, et al.
Successful childbirth in a patient with chronic myelogenous leukemia treated with imatinib mesylate during early pregnancy. [Journal Article]
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2008 Jun; 152(1):121-3.
Abstract | Full Citation | Find Related Articles | | Hazarika M, Jiang X, Liu Q, et al.
Tasigna for chronic and accelerated phase Philadelphia chromosome-positive chronic myelogenous leukemia resistant to or intolerant of imatinib. [Journal Article]
Clin Cancer Res 2008 Sep 1; 14(17):5325-31.
Abstract | Full Citation | | Wong SF
Dasatinib dosing strategies in Philadelphia chromosome-positive leukemia. [JOURNAL ARTICLE]
J Oncol Pharm Pract 2008 Aug 27.
Abstract | Full Citation | Find Related Articles | | Wei L, Xiao LL, Wu XY, et al.
[Expression and Analysis of HLA-A, B and DRB1 Genes in Patients with Chronic Myelogenous Leukemia in Guangdong Area.] [English Abstract, Journal Article]
Zhongguo Shi Yan Xue Ye Xue Za Zhi 2008 Aug; 16(4):915-8.
Abstract | Full Citation | Find Related Articles | | Zhang M, Fu W, Prabhu S, et al.
Inhibition of Polysome Assembly Enhances Imatinib Activity Against Chronic Myelogenous Leukemia, and Overcomes Imatinib Resistance. [JOURNAL ARTICLE]
Mol Cell Biol 2008 Aug 11.
Abstract | Full Citation | | Shah NP
Advanced CML: therapeutic options for patients in accelerated and blast phases. [Journal Article]
J Natl Compr Canc Netw 2008 Mar.:S31-S36.
Abstract | Full Citation | Find Related Articles |   |
|
| |
Advertise on this site.
|
